MedPath

Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial

Not Applicable
Completed
Conditions
Chronic Pain
Interventions
Device: Programming
Registration Number
NCT02988713
Lead Sponsor
Boston Scientific Corporation
Brief Summary

This is a prospective, multi-center, non-randomized, exploratory, single-arm study characterize the effects of programming spinal cord stimulation (SCS) in patients undergoing a Boston Scientific (BSC) spinal cord stimulation (SCS) temporary trial

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Study candidate is undergoing a spinal cord stimulation (SCS) trial of BSC neurostimulation system, per local directions for use (DFU).
  • Subject signed a valid, Institutional Review Board (IRB)-approved informed consent form.
  • Subject is 18 years of age or older when written informed consent is obtained.

Key

Exclusion Criteria
  • Subject meets any contraindication in BSC neurostimulation system local directions for use (DFU).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Spinal cord stimulationProgrammingSpinal cord stimulation (SCS) in patients undergoing a Boston Scientific (BSC) spinal cord stimulation (SCS) temporary trial
Primary Outcome Measures
NameTimeMethod
Patient ComfortAn estimated average of 7 days post temporary trial procedure

Number of participants reporting comfort level of stimulation sensation as "Very Comfortable" or "Slightly Comfortable"

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Pacific Pain Management, Inc.

🇺🇸

Ventura, California, United States

PCPMG Clinical Research Unit, LLC

🇺🇸

Greenville, South Carolina, United States

Pacific Pain Management, Inc.
🇺🇸Ventura, California, United States
© Copyright 2025. All Rights Reserved by MedPath